← Eichor
Study identifier: NCT06755359 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Condition: Pancreatic Cancer · Locally Advanced Pancreatic Cancer  ·  Sponsor: Alpha Tau Medical LTD.

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

About this study

A unique approach for cancer treatment including radioactive sources named Alpha DaRT sources: Ra - 224 coated onto stainless steel tubes inserted into the tumor for the treatment of Locally Advanced Pancreatic Cancer .

This description comes directly from the study's public registry record.

Talk to the study team

Liron Dimnik  ·  972-54-2688602  ·  LironD@alphatau.com

Aviya Hoida  ·  972-54-7869466  ·  aviyah@alphatau.com

Always discuss trial participation with your own doctor first.

Locations (12)

CHU de BordeauxBordeaux, FranceNot Yet Recruiting
CHU de BordeauxBordeaux, FranceNot Yet Recruiting
Centre Jean PERRIN - Clermont-FerrandClermont-Ferrand, FranceNot Yet Recruiting
Centre Georges François Leclerc DijonDijon, FranceNot Yet Recruiting
Centre Georges François Leclerc DijonDijon, FranceNot Yet Recruiting
Centre Georges François Leclerc DijonDijon, FranceNot Yet Recruiting
CHU Grenoble AlpesGrenoble, FranceRecruiting
Hôpital Privé Mermoz - LyonLyon, FranceNot Yet Recruiting
MarseilleMarseille, FranceNot Yet Recruiting
CHU PoitiersPoitiers, FranceNot Yet Recruiting
CHU PoitiersPoitiers, FranceNot Yet Recruiting
Gustave Roussy InstituteVillejuif, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06755359